Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.060
-0.250 (-5.80%)
Jan 28, 2026, 4:00 PM EST - Market closed

Exagen Revenue

Exagen had revenue of $17.24M in the quarter ending September 30, 2025, with 37.87% growth. This brings the company's revenue in the last twelve months to $63.60M, up 14.08% year-over-year. In the year 2024, Exagen had annual revenue of $55.64M with 5.89% growth.

Revenue (ttm)
$63.60M
Revenue Growth
+14.08%
P/S Ratio
1.29
Revenue / Employee
$295,809
Employees
215
Market Cap
92.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 201832.44M5.63M21.01%
Dec 31, 201726.81M8.86M49.38%
Dec 31, 201517.95M6.28M53.87%
Dec 31, 201411.66M8.61M281.77%
Dec 31, 20133.06M2.13M229.91%
Dec 31, 2012926.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics825.30M
Inotiv513.02M
FONAR105.43M
MDxHealth103.07M
Biodesix80.17M
Prenetics Global77.08M
Burning Rock Biotech75.75M
Precipio22.80M
Revenue Rankings